欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0110/009
药品名称
Topimax
活性成分
Topiramate 50.0 mg
剂型
Capsule, hard
上市许可持有人
Janssen-Cilag AB Sollentuna Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Netherlands (NL)
Finland (FI)
Italy (IT)
Germany (DE)
Denmark (DK)
Belgium (BE)
Luxembourg (LU)
Iceland (IS)
Austria (AT)
Topamax 50 mg Granulat in Kapseln
France (FR)
Spain (ES)
Portugal (PT)
Greece (GR)
Norway (NO)
Cyprus (CY)
Malta (MT)
Topamax
许可日期
2000/12/21
最近更新日期
2025/01/16
药物ATC编码
N03AX11 topiramate
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Other Article 4.8(a)(iii), second paragraph
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_0110_009_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_0110_009_Final SPC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase